Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01419431
Other study ID # SOCS3 mRNA
Secondary ID SOCS-3-202008
Status Completed
Phase N/A
First received July 18, 2011
Last updated December 15, 2011
Start date January 2007
Est. completion date December 2011

Study information

Verified date December 2011
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority Norway: Regional Ethics Commitee
Study type Observational

Clinical Trial Summary

Pro-inflammatory responses following laparoscopic surgery.


Description:

Blood samples from 20 patient with colon cancer collected before and in 3 days following laparoscopic surgery. Analyzed for inflammatory cytokines and corresponding SOCS3 mRNA.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date December 2011
Est. primary completion date November 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:Colon cancer stage I-III -

Exclusion Criteria:Colon cancer stage IV

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Regulation of Inflammatory Response

Intervention

Procedure:
Laparoscopic resection
Inflammatory response in laparoscopic surgery

Locations

Country Name City State
Norway Oslo University Hospital Oslo

Sponsors (1)

Lead Sponsor Collaborator
Oslo University Hospital

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Inflammatory values for laparoscopic resection for colon cancer. Corresponding values of SOCS3 mRNA copared to inflammatory cytokines in patients with laparoscopic resection for colon cancer. 3 days No
See also
  Status Clinical Trial Phase
Recruiting NCT04517162 - Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients Phase 1/Phase 2